Manejo de náuseas y vómitos inducidos por quimioterapia en pacientes hematológicos
Publicado
jul 1, 2021
Almetrics
Dimensions
Google Scholar
##plugins.themes.bootstrap3.article.details##
Resumen
Las náuseas y vómitos (NyV) constituyen dos de los efectos adversos frecuentemente asociados a la administración de quimioterapia además de otros fármacos empleados en hematología. La importancia que la prevención y el manejo de estos síntomas tiene en nuestros pacientes, radica en los riesgos que representan cuando no son tratados correctamente como por ejemplo: deshidratación, alteraciones hidroelectrolíticas e insuficiencia renal aguda. Para la elaboración este artículo se realizó una revisión de la literatura en función de la evidencia y esquemas disponibles para la prevención y tratamiento de NV inducido por medicamentos usados en el manejo de pacientes con patologías hematológicas.
Keywords
Treatment, Náusea, Vomiting, Chemotherapy, HematologyTratamiento, Náusea, Vómito, Quimioterapia, Hematología
References
1. Clark-Snow, R., Affronti, M. L., & Rittenberg, C. N. (2018). Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 26(2), 557–564. https://doi.org/10.1007/s00520-017-3866-6
2. Ferretiz López, G., Cuéllar Guzmán, L. F., & Cárdenas Herrera, N. (2020). Clasificación y tratamiento de náusea y vómito postoperatorio en el paciente oncológico sometido a cirugía. Revista Chilena de Anestesia, 49(2), 223-236. https://doi.org/10.25237/revchilanestv49n02.07
3. Singh, P., Yoon, S. S., & Kuo, B. (2016). Nausea: a review of pathophysiology and therapeutics. Therapeutic advances in gastroenterology, 9(1), 98–112. https://doi.org/10.1177/1756283X15618131
4. Veiga-Gil, L., Pueyo, J., & López-Olaondo, L. (2017). Náuseas y vómitos postoperatorios: fisiopatología, factores de riesgo, profilaxis y tratamiento. Revista Española de Anestesiología y Reanimación, 64(4), 223-232. https://doi.org/10.1016/j.redar.2016.10.001
5. Aapro M. (2018). CINV: still troubling patients after all these years. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 26(Suppl 1), 5–9. https://doi.org/10.1007/s00520-018-4131-3
6. Alamri, A., Alawlah, Y. A., Qiao, Y., & Wang, J. (2018). A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting. SAGE open medicine, 6, 2050312118767234. https://doi.org/10.1177/2050312118767234
7. Hesketh Paul J, Kris Mark G, Basch Ethan, Bohlke Kari, Barbour Sally Y, Clark-Snow Rebecca Anne, Danso Michael A, Dennis Kristopher, Dupuis L Lee, Dusetzina Stacie B, Eng Cathy, Feyer Petra C, Jordan Karin, Noonan Kimberly, Sparacio Dee, Somerfield Mark R, Lyman Gary H. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35:3240–3261.
8. Vaid, A. K., Gupta, S., Doval, D. C., Agarwal, S., Nag, S., Patil, P., Goswami, C., Ostwal, V., Bhagat, S., Patil, S., & Barkate, H. (2020). Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. Frontiers in oncology, 10, 400. https://doi.org/10.3389/fonc.2020.00400
9. Viale P. H. (2018). Chemotherapy-Induced Nausea and Vomiting: Updates and Recommendations. Journal of the advanced practitioner in oncology, 9(2), 150–152.
10. Jordan K, Blättermann L, Hinke A, Müller-Tidow C, Jahn F. Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis. Support Care Cancer. 2018;26(1):21-32. doi:10.1007/s00520-017-3857-7
11. Masiongale AJ, Garvin JT, Murphy MJ, et al. Reexamining Metoclopramide's Role in the Prevention of Postoperative Nausea and Vomiting: A Secondary Analysis. AANA J. 2018;86(3):213-219.
12. Rasheed, M. A., Sarkar, A., & Arora, V. (2019). Evaluation of Efficacy of Metoclopramide, Dexamethasone and Their Combination for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Cesarean Section. Anesthesia and Critical Care, 01(01), 1-9. https://doi.org/10.26502/acc.001
13. Hesketh, P. J., Aapro, M., Jordan, K., Schwartzberg, L., Bosnjak, S., & Rugo, H. (2015). A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting. BioMed research international, 2015, 651879. https://doi.org/10.1155/2015/651879
14. Umar, R. M. (2018). Drug-drug interactions between antiemetics used in cancer patients. Journal of Oncological Sciences, 4(3), 142-146. https://doi.org/10.1016/j.jons.2018.07.003
15. Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R. J., Bruera, E., van der Wetering, M. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology, 27, v119-v133. https://doi.org/10.1093/annonc/mdw270
2. Ferretiz López, G., Cuéllar Guzmán, L. F., & Cárdenas Herrera, N. (2020). Clasificación y tratamiento de náusea y vómito postoperatorio en el paciente oncológico sometido a cirugía. Revista Chilena de Anestesia, 49(2), 223-236. https://doi.org/10.25237/revchilanestv49n02.07
3. Singh, P., Yoon, S. S., & Kuo, B. (2016). Nausea: a review of pathophysiology and therapeutics. Therapeutic advances in gastroenterology, 9(1), 98–112. https://doi.org/10.1177/1756283X15618131
4. Veiga-Gil, L., Pueyo, J., & López-Olaondo, L. (2017). Náuseas y vómitos postoperatorios: fisiopatología, factores de riesgo, profilaxis y tratamiento. Revista Española de Anestesiología y Reanimación, 64(4), 223-232. https://doi.org/10.1016/j.redar.2016.10.001
5. Aapro M. (2018). CINV: still troubling patients after all these years. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 26(Suppl 1), 5–9. https://doi.org/10.1007/s00520-018-4131-3
6. Alamri, A., Alawlah, Y. A., Qiao, Y., & Wang, J. (2018). A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting. SAGE open medicine, 6, 2050312118767234. https://doi.org/10.1177/2050312118767234
7. Hesketh Paul J, Kris Mark G, Basch Ethan, Bohlke Kari, Barbour Sally Y, Clark-Snow Rebecca Anne, Danso Michael A, Dennis Kristopher, Dupuis L Lee, Dusetzina Stacie B, Eng Cathy, Feyer Petra C, Jordan Karin, Noonan Kimberly, Sparacio Dee, Somerfield Mark R, Lyman Gary H. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35:3240–3261.
8. Vaid, A. K., Gupta, S., Doval, D. C., Agarwal, S., Nag, S., Patil, P., Goswami, C., Ostwal, V., Bhagat, S., Patil, S., & Barkate, H. (2020). Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. Frontiers in oncology, 10, 400. https://doi.org/10.3389/fonc.2020.00400
9. Viale P. H. (2018). Chemotherapy-Induced Nausea and Vomiting: Updates and Recommendations. Journal of the advanced practitioner in oncology, 9(2), 150–152.
10. Jordan K, Blättermann L, Hinke A, Müller-Tidow C, Jahn F. Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis. Support Care Cancer. 2018;26(1):21-32. doi:10.1007/s00520-017-3857-7
11. Masiongale AJ, Garvin JT, Murphy MJ, et al. Reexamining Metoclopramide's Role in the Prevention of Postoperative Nausea and Vomiting: A Secondary Analysis. AANA J. 2018;86(3):213-219.
12. Rasheed, M. A., Sarkar, A., & Arora, V. (2019). Evaluation of Efficacy of Metoclopramide, Dexamethasone and Their Combination for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Cesarean Section. Anesthesia and Critical Care, 01(01), 1-9. https://doi.org/10.26502/acc.001
13. Hesketh, P. J., Aapro, M., Jordan, K., Schwartzberg, L., Bosnjak, S., & Rugo, H. (2015). A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting. BioMed research international, 2015, 651879. https://doi.org/10.1155/2015/651879
14. Umar, R. M. (2018). Drug-drug interactions between antiemetics used in cancer patients. Journal of Oncological Sciences, 4(3), 142-146. https://doi.org/10.1016/j.jons.2018.07.003
15. Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R. J., Bruera, E., van der Wetering, M. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology, 27, v119-v133. https://doi.org/10.1093/annonc/mdw270
Cómo citar
Ávila Rueda, J. A., Flegler, N., Oliveros, K., Rivarola, S., Montes, A., De Muria, M., Sernaque, C., Cantillo, A. M., Carreras, M. ., Zapata, L., & Palmer, S. (2021). Manejo de náuseas y vómitos inducidos por quimioterapia en pacientes hematológicos. Universitas Medica, 62(3). https://doi.org/10.11144/Javeriana.umed62-3.mnvi
Número
Sección
Revisión de tema
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.